➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
AstraZeneca
Boehringer Ingelheim
Dow
Johnson and Johnson
Express Scripts

Last Updated: August 4, 2020

DrugPatentWatch Database Preview

RIFAMPIN Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Rifampin, and what generic alternatives are available?

Rifampin is a drug marketed by Akorn, Lannett Co Inc, Lupin Pharms, Sandoz, Emcure Pharms Ltd, Fresenius Kabi Usa, Hikma Pharms, Mylan Labs Ltd, Watson Pharms Teva, West-ward Pharms Int, and Hikma Intl Pharms. and is included in twelve NDAs.

The generic ingredient in RIFAMPIN is isoniazid; rifampin. There are five drug master file entries for this compound. Additional details are available on the isoniazid; rifampin profile page.

Drug patent expirations by year for RIFAMPIN
Drug Prices for RIFAMPIN

See drug prices for RIFAMPIN

Recent Clinical Trials for RIFAMPIN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of Texas Southwestern Medical CenterPhase 2
Odonate Therapeutics, Inc.Phase 1
Fifth Affiliated Hospital, Sun Yat-Sen UniversityN/A

See all RIFAMPIN clinical trials

Pharmacology for RIFAMPIN

US Patents and Regulatory Information for RIFAMPIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Akorn RIFAMPIN rifampin CAPSULE;ORAL 065028-001 Mar 14, 2001 AB RX No No   Start Trial   Start Trial   Start Trial
Sandoz RIFAMPIN rifampin CAPSULE;ORAL 064150-002 Jan 2, 1998 AB RX No No   Start Trial   Start Trial   Start Trial
Lannett Co Inc RIFAMPIN rifampin CAPSULE;ORAL 065390-002 Mar 28, 2008 AB RX No No   Start Trial   Start Trial   Start Trial
Hikma Pharms RIFAMPIN rifampin INJECTABLE;INJECTION 205039-001 Mar 3, 2016 AP RX No No   Start Trial   Start Trial   Start Trial
Sandoz RIFAMPIN rifampin CAPSULE;ORAL 064150-001 May 28, 1997 AB RX No No   Start Trial   Start Trial   Start Trial
Hikma Intl Pharms RIFAMPIN AND ISONIAZID isoniazid; rifampin CAPSULE;ORAL 065221-001 Jul 29, 2005 DISCN No No   Start Trial   Start Trial   Start Trial
Watson Pharms Teva RIFAMPIN rifampin INJECTABLE;INJECTION 206736-001 Jan 19, 2016 AP RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Express Scripts
Baxter
Dow
Merck
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.